Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>Marta Milà‐Alomà, Eider M. Arenaza‐Urquijo, Marta Crous‐Bou et al.|Alzheimer s & Dementia|2020Cited by 260
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E. Collij, María Pascual, Fiona Heeman et al.|Neurology|2020Cited by 101
Associations between air pollution and biomarkers of Alzheimer’s disease in cognitively unimpaired individualsSilvia Alemany, José Luís Molinuevo, Marta Crous‐Bou et al.|Environment International|2021Cited by 99
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuumNatàlia Vilor‐Tejedor, Marc Vilanova, Iacopo Ciampa et al.|Alzheimer s Research & Therapy|2021Cited by 68